日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models

西妥昔单抗可增加 LGR5 表达,并增强 LGR5 靶向抗体药物偶联物在患者来源的结直肠癌模型中的疗效。

High, Peyton C; Liang, Zhengdong; Guernsey-Biddle, Cara; Subramanian, Shraddha; Shyu, Yueh-Ming; Aldana, Adela M; Toh, Yukimatsu; Carmon, Kendra S

Assembly of MSCs into a spheroid configuration increases poly(I:C)-mediated TLR3 activation and the immunomodulatory potential of MSCs for alleviating murine colitis.

将 MSC 组装成球状体构型可增强 poly(I:C) 介导的 TLR3 激活,并增强 MSC 缓解小鼠结肠炎的免疫调节潜力

Ho Chao-Ting, Kao Ying-Chi, Shyu Yueh-Ming, Wang I-Ching, Liu Qiao-Xuan, Liu Shao-Wen, Huang Shih-Chen, Chiu Han, Hsu Li-Wen, Hsu Tzu-Sheng, Hsieh Wan-Chen, Huang Chieh-Cheng

Cetuximab increases LGR5 expression and augments LGR5-targeting antibody-drug conjugate efficacy in patient-derived colorectal cancer models.

西妥昔单抗可增加 LGR5 表达,并增强 LGR5 靶向抗体药物偶联物在患者来源的结直肠癌模型中的疗效

High Peyton C, Liang Zhengdong, Guernsey-Biddle Cara, Subramanian Shraddha, Shyu Yueh-Ming, Aldana Adela M, Toh Yukimatsu, Carmon Kendra S